financetom
Market
financetom
/
Market
/
This Analyst With 86% Accuracy Rate Sees Around 16% Upside In Alphabet - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
This Analyst With 86% Accuracy Rate Sees Around 16% Upside In Alphabet - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts
Jul 22, 2024 5:12 AM

U.S. stocks closed lower on Friday, with the Dow Jones index falling more than 350 points during the session.

The S&P 500 fell 1.97%, while the Nasdaq dipped 3.65% last week, recording their biggest weekly losses since April. However, the Dow gained 0.72% during the week.

Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all analysts have particularly impressive track records at predicting market movements. Even when it comes to one single stock, analyst ratings and price targets can vary widely, leaving investors confused about which analyst’s opinion to trust.

Benzinga’s Analyst Ratings API is a collection of the highest-quality stock ratings curated by the Benzinga news desk via direct partnerships with major sell-side banks. Benzinga displays overnight ratings changes on a daily basis three hours prior to the U.S. equity market opening. Data specialists at investment dashboard provider Toggle.ai recently uncovered that the analyst insights Benzinga Pro subscribers and Benzinga readers regularly receive can successfully be used as trading indicators to outperform the stock market.

Top Analyst Picks: Fortunately, any Benzinga reader can access the latest analyst ratings on the Analyst Stock Ratings page. One of the ways traders can sort through Benzinga’s extensive database of analyst ratings is by analyst accuracy. Here’s a look at the most recent stock picks from each of the five most accurate Wall Street analysts, according to Benzinga Analyst Stock Ratings.

Analyst: John Todaro

Analyst Firm: Needham

Ratings Accuracy: 87%

Latest Rating: Reiterated a Buy rating on Coinbase Global, Inc. ( COIN ) with a price target of $260 on July 19. This analyst sees around 1% increase in the stock.

Recent News: Coinbase Global ( COIN ) is expected to report its second quarter 2024 financial results on Thursday, Aug. 1, 2024, after the closing bell.

Analyst: Justin Post

Analyst Firm: B of A Securities

Ratings Accuracy: 86%

Latest Rating: Maintained a Buy rating on Alphabet Inc. ( GOOG ) and increased the price target from $200 to $206 on July 17. This analyst sees around 16% upside in the stock.

Recent News: Alphabet’s Google revealed its upcoming Pixel 9 flagship smartphones before they can be leaked yet again.

Analyst: Alexander Paris

Analyst Firm: Barrington Research

Ratings Accuracy: 85%

Latest Rating: Maintained an Outperform rating on Perdoceo Education Corporation ( PRDO ) and boosted the price target from $25 to $27 on July 16. This analyst sees around 15% upside in the stock.

Recent News: Perdoceo Education ( PRDO ) will report second quarter 2024 financial results after the closing bell on Wednesday, July 31.

Analyst: Brian Mullan

Analyst Firm: Piper Sandler

Ratings Accuracy: 85%

Latest Rating: Maintained a Neutral rating on Chipotle Mexican Grill, Inc. ( CMG ) and cut the price target from $61.4 to $60 on July 16. This analyst sees around 12% gain in the stock.

Recent News: Chipotle is scheduled to host a conference call on Wednesday, July 24, to discuss second quarter financial results.

Analyst: Lauren Silberman

Analyst Firm: Deutsche Bank

Ratings Accuracy: 85%

Latest Rating: Maintained a Buy rating on McDonald’s Corporation and cut the  price target from $310 to $295 on July 16. This analyst sees around 15% upside in the stock.

Recent News: On June 21, McDonald’s announced a new $5 meal deal to attract price-conscious customers amid rising fast-food prices.

Read More:

Top 3 Industrials Stocks That May Rocket Higher In Q3

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sector Update: Tech
Sector Update: Tech
Jun 3, 2024
08:46 AM EDT, 06/03/2024 (MT Newswires) -- Technology stocks were mixed premarket Monday, with the Technology Select Sector SPDR Fund (XLK) up 0.6% and the SPDR S&P Semiconductor ETF (XSD) down 3.2%. Spotify Technology ( SPOT ) shares were over 5% higher after the company said it is increasing prices for its premium plans in the US, starting in July....
This Analyst With 85% Accuracy Rate Sees Over 29% Upside In MongoDB - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts
This Analyst With 85% Accuracy Rate Sees Over 29% Upside In MongoDB - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts
Jun 3, 2024
U.S. stocks settled mostly higher on Friday, with the Dow Jones index recording its best session of the year. However, U.S. stocks recorded losses last week, with the S&P 500 falling 0.51% and the Dow Jones index declining 0.98% during the week. Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all analysts have...
Sector Update: Financial
Sector Update: Financial
Jun 3, 2024
08:54 AM EDT, 06/03/2024 (MT Newswires) -- Financial stocks were steady pre-bell Monday with the Financial Select Sector SPDR Fund (XLF) recently unchanged. The Direxion Daily Financial Bull 3X Shares (FAS) was 0.2% higher and its bearish counterpart Direxion Daily Financial Bear 3X Shares (FAZ) was down 0.3%. Fanhua ( FANH ) said it will collaborate with Baidu ( BIDU...
Sector Update: Health Care
Sector Update: Health Care
Jun 3, 2024
08:49 AM EDT, 06/03/2024 (MT Newswires) -- Health care stocks were steady premarket Monday as the Health Care Select Sector SPDR Fund (XLV) and iShares Biotechnology ETF (IBB) were recently inactive. GSK (GSK) shares fell by about 8% after a Delaware court ruled Friday that the company should face trials over allegations that its heartburn treatment Zantac causes cancer. ...
Copyright 2023-2025 - www.financetom.com All Rights Reserved